Skip to content
TrustList
Logos Capital logo
Venture capital firm

Logos Capital

San Francisco biotechnology investment partnership using in-house clinical trial analytics

Logos Capital cover

About Logos Capital

Logos Capital is a biotechnology-focused investment partnership based in San Francisco. It pairs scientific and financial skills with clinical trial analytics done in-house. The name comes from the Greek word for logic and discourse.

Services

  • Biotechnology investing: direct investment in public and private companies in the sector.
  • Clinical trial underwriting: analysis of trial data as part of each investment decision.
  • Event tracking and risk management: systematic follow-up of company milestones and risks.
  • Asset assessment: reviews assets from preclinical data through to commercial potential.

Who it serves

Biotechnology companies working on new therapies. Portfolio companies named on its site include Aligos Therapeutics, ALX Oncology, Annexon Biosciences, Athira Pharma and Avidity Biosciences.

Key facts

  • Based in: San Francisco, USA
  • Team backgrounds: chemistry, engineering, biology and data science, plus medical, scientific and statistical disciplines

Profile written by TrustList from the business's own published information, Oct 2026.

Categories & features

Ask TrustList to introduce you to Logos Capital

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA — Google Privacy Policy and Terms apply.

Reviews

Write the first review of Logos Capital

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about Logos Capital.

Logos Capital alternatives

Similar listings buyers compare against this one.

Startup accelerator running programmes for early-stage and scaling technology founders in the North East of England

Member-based investor group funding early-stage companies through monthly review and a chapter roadshow

Startup accelerator and early-stage investor running intensive batches for new technology founders

Venture capital firm partnering with founders from first idea through to public listing

Global venture capital firm and accelerator backing early-stage technology founders, formerly called 500 Startups

Decentralised bandwidth network on which developers build and users run censorship-resistant VPN applications